Viewing Study NCT03999658

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:09 AM
Ignite Modification Date: 2026-01-10 @ 3:02 PM
Study NCT ID: NCT03999658
Status: WITHDRAWN
Last Update Posted: 2023-05-01
First Post: 2019-06-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies
Sponsor: Sorrento Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral T Cell Lymphoma View
None Diffuse Large B Cell Lymphoma View
None Biliary Tract Cancer View
None Extranodal NK T Cell Lymphoma, Nasal View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ENKTL View
None DLBCL View
None PTCL View
None cholangiocarcinoma View
None gall bladder cancer View
None relapsed View
None refractory View
None T/NK-cell View
None NK/T-cell View
None peripheral T-cell View
None PD-L1 View
None anti-PD-L1 antibody View